Therapeutics / Biotech / BioTech / Drugs / Drug

Using an old Merck drug, Menlo hopes to scratch an itch with $98M IPO

Posted on: Dec 30, 2017   |   Posted by: Biotech Mag Top

Six months after getting off a $50 million series C, late-stage California dermatology biotech Menlo Therapeutics is looking to take advantage of the strong IPO window with a...